Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT00255359
What this trial is testing

Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers

Who this might be right for
Chronic Hepatitis C Virus Infection
Hadassah Medical Organization 60
Early research (Phase 1)Study completedNCT02780674
What this trial is testing

MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases

Who this might be right for
Dermatomyositis, Polymyositis, Sjogren's, SLE, SSc
Amgen 36
Testing effectiveness (Phase 2)Ended earlyNCT00006113
What this trial is testing

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University of Southern California 25
Not applicableLooking for participantsNCT07249060
What this trial is testing

Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients

Who this might be right for
Immune-Related Adverse EventsLupus Erythematosus, SystemicSjogren Syndrome+3 more
Hospital Universitario Araba 300
Early research (Phase 1)UnknownNCT02364986
What this trial is testing

Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
PD Dr. Marcus Müller 50
Post-approval studies (Phase 4)Study completedNCT02804386
What this trial is testing

Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon

Who this might be right for
Hepatitis C, Chronic
PharmEvo Pvt Ltd 573
Large-scale testing (Phase 3)Study completedNCT05378646
What this trial is testing

Efficiency and Safety of the Drug Ingaron (Interferon-gamma Human Recombinant) in the Treatment of Chronic Prostatitis

Who this might be right for
Chronic Prostatitis
SPP Pharmaclon Ltd. 30
Not applicableStudy completedNCT00595907
What this trial is testing

Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis

Who this might be right for
Tuberculosis
University Hospital, Geneva 89
Not applicableUnknownNCT02412592
What this trial is testing

Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 260
Post-approval studies (Phase 4)Ended earlyNCT00255034
What this trial is testing

Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 146
Large-scale testing (Phase 3)UnknownNCT00209209
What this trial is testing

Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL

Who this might be right for
Lymphoma, Mantle-Cell
European Mantle Cell Lymphoma Network 570
Early research (Phase 1)Study completedNCT01901198
What this trial is testing

Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase I Study in Chinese Healthy Volunteers

Who this might be right for
Healthy Volunteers
Beijing Bio-Fortune Ltd. 34
Testing effectiveness (Phase 2)Study completedNCT01706575
What this trial is testing

Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) Suppression

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 76
Not applicableLooking for participantsNCT05775211
What this trial is testing

Effects of Intrauterine Administration of Autologous PBMC Modulated With IFNt on Endometrial Cell Populations

Who this might be right for
Infertility
Nadezhda Women's Health Hospital 300
Testing effectiveness (Phase 2)Study completedNCT01156311
What this trial is testing

BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple SclerosisMultiple Sclerosis
Biogen 108
Testing effectiveness (Phase 2)WithdrawnNCT05936229
What this trial is testing

Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy

Who this might be right for
Recurrent B Acute Lymphoblastic LeukemiaRecurrent B-Cell Non-Hodgkin LymphomaRefractory B Acute Lymphoblastic Leukemia+3 more
Fred Hutchinson Cancer Center
Post-approval studies (Phase 4)Study completedNCT00686777
What this trial is testing

Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 75
Not applicableStudy completedNCT02794636
What this trial is testing

Interferon Toxicities in Melanoma Treatment

Who this might be right for
Stage III Melanoma
Bristol-Myers Squibb 436
Testing effectiveness (Phase 2)Study completedNCT00006244
What this trial is testing

Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Center 36
Early research (Phase 1)Study completedNCT00031083
What this trial is testing

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma, Mixed+1 more
Biogen 12
Next Page